Literature DB >> 16832642

[Is there a pharmacotherapy for libido disturbances in men?].

F-M Köhn1.   

Abstract

For men with a reduced testosterone level, treatment with testosterone usually improves sexual appetency. This has been demonstrated for gel and plaster as well as intramuscular and oral forms of treatment. However, from our current stand point such disturbances in sexual appetency can only be treated pharmacologically if these result from an endocrinological or other disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16832642     DOI: 10.1007/s00120-006-1126-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  20 in total

1.  Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

Authors:  Christina Wang; Glenn Cunningham; Adrian Dobs; Ali Iranmanesh; Alvin M Matsumoto; Peter J Snyder; Thomas Weber; Nancy Berman; Laura Hull; Ronald S Swerdloff
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

2.  Sexual functioning and satisfaction in nonresponders to testosterone gel: Potential effectiveness of retreatment in hypogonadal males.

Authors:  Christopher Steidle; Michael A Witt; Justin Matrisciano; Jon E Block
Journal:  Clin Cornerstone       Date:  2005

3.  Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction.

Authors:  H J Vogt; P Brandl; G Kockott; J R Schmitz; M H Wiegand; J Schadrack; M Gierend
Journal:  Int J Impot Res       Date:  1997-09       Impact factor: 2.896

4.  Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status.

Authors:  Matthew Haren; Ian Chapman; Penelope Coates; John Morley; Gary Wittert
Journal:  Age Ageing       Date:  2004-12-13       Impact factor: 10.668

Review 5.  Dopamine and sexual function.

Authors:  F Giuliano; J Allard
Journal:  Int J Impot Res       Date:  2001-08       Impact factor: 2.896

6.  Piracetam therapy does not enhance cognitive functioning in children with down syndrome.

Authors:  N J Lobaugh; V Karaskov; V Rombough; J Rovet; S Bryson; R Greenbaum; R H Haslam; G Koren
Journal:  Arch Pediatr Adolesc Med       Date:  2001-04

Review 7.  Quinagolide--a valuable treatment option for hyperprolactinaemia.

Authors:  Anne Barlier; Philippe Jaquet
Journal:  Eur J Endocrinol       Date:  2006-02       Impact factor: 6.664

8.  Sexual problems of male patients in family practice.

Authors:  C Aschka; W Himmel; E Ittner; M M Kochen
Journal:  J Fam Pract       Date:  2001-09       Impact factor: 0.493

9.  The relationship between libido and testosterone levels in aging men.

Authors:  Thomas G Travison; John E Morley; Andre B Araujo; Amy B O'Donnell; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2006-05-02       Impact factor: 5.958

10.  Sexual dysfunction in the United States: prevalence and predictors.

Authors:  E O Laumann; A Paik; R C Rosen
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.